BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30
• 31

• Press Releases

  Artelo Biosciences Receives FDA Clearance of its IND Application for ART26.12, a Selective Fatty Acid Binding Protein 5 Inhibitor

  July 15, 2024

   · 

  5 min read
• Press Releases

  Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for People With Cystic Fibrosis Aged 2 Years and Older With Certain Rare Mutations

  July 15, 2024

   · 

  6 min read
• Press Releases

  First Type 1 Diabetes Patient Enrolled in Rise Therapeutics’ Latest Clinical Trial

  July 15, 2024

   · 

  2 min read
• Press Releases

  Cytonics Announces Initiation Of First-In-Human Phase 1 Clinical Study For CYT-108 In Patients Suffering From Osteoarthritis Of The Knee

  July 15, 2024

   · 

  6 min read
• 

  Press Releases

  Hepatitis C Market Estimated to Reach USD 47.1 Billion by 2034, Impelled by Combination Therapy Involving Immune Modulator Drugs and Nucleoside Analogs

  July 15, 2024

   · 

  11 min read
• 

  Press Releases

  Head and Neck Squamous Cell Carcinoma Market Estimated to Reach USD 2.4 Billion by 2034, Impelled by Widespread Adoption of Targeted Drugs

  July 15, 2024

   · 

  12 min read
• 

  Press Releases

  Pollen Allergy Market Estimated to Reach a CAGR of 2.79% during 2024-2034, Impelled by Sublingual Immunotherapy Treatment

  July 15, 2024

   · 

  12 min read
• 

  Press Releases

  Pneumonia Market to Grow at 5.32% During 2024-2034, Facilitated by Adoption of Advanced Treatments

  July 15, 2024

   · 

  9 min read
• Press Releases

  Glen Clova Scientific appoints Amanda Mackenzie as Director of R&D Operations

  · Mackenzie brings 10 years’ expertise in the UK pharma, biotech, CRO, and academic sectors · Tasked with driving development of GCS’s pipeline of next generation Active Biologic Drugs

  July 15, 2024

   · 

  1 min read
• Press Releases

  PepGen Appoints Afsaneh Mohebbi, Ph.D., as SVP, Portfolio and Program Management and Dave Borah, CFA, as SVP, Investor Relations and Corporate Communications

  July 15, 2024

   · 

  3 min read